APA (7th ed.) Citation

BA, M., L, K., W, X., JA, E., ND, J., HM, S., . . . AV, D. (2023). Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis. JAMA network open, 6(11), e2340787. https://doi.org/10.1001/jamanetworkopen.2023.40787

Chicago Style (17th ed.) Citation

BA, Mahal, et al. "Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis." JAMA Network Open 6, no. 11 (2023): e2340787. https://doi.org/10.1001/jamanetworkopen.2023.40787.

MLA (9th ed.) Citation

BA, Mahal, et al. "Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis." JAMA Network Open, vol. 6, no. 11, 2023, p. e2340787, https://doi.org/10.1001/jamanetworkopen.2023.40787.